Organization · Venture Capital
Ambria Capital, LLC
Ambria Capital, LLC is a venture capital firm based in San Juan, Puerto Rico, focused on early-stage investments in the mental health and technology sectors, particularly in psychedelic-assisted therapies.
Overview
What Ambria Capital, LLC does
What Ambria Capital, LLC is
Ambria Capital, LLC is a venture capital firm based in San Juan, Puerto Rico, focused on early-stage investments in the mental health and technology sectors, particularly in psychedelic-assisted therapies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Ambria Capital, LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Ambria Capital, LLC as a funder
Investment thesis
Ambria Capital, LLC is focused on empowering early-stage companies in the mental health and technology sectors, particularly through investments in psychedelic-assisted therapies.
Focus narrative
Ambria Capital invests primarily in sectors such as psychedelics, digital health, cryptocurrency, and cybersecurity. The firm is particularly interested in companies that are pioneering psychedelic-assisted therapies, which they view as a significant innovation in mental healthcare. By focusing on these areas, Ambria Capital seeks to back companies that are positioned to make a meaningful impact on mental health treatment.
Value beyond capital
Ambria Capital adds value to its portfolio companies by leveraging its expertise in the mental health and psychedelic sectors, providing strategic guidance, and facilitating connections within the industry. The firm actively participates in funding rounds and demonstrates a commitment to follow-on investments, ensuring that its portfolio companies have the necessary resources to grow and succeed.
Terms and economics
- Typical check
- $2,000,000–$5,000,000
- Sweet spot
- $3,000,000
Focus and fit
- Stages
- Seed · Series A · Series C
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
- Recorded notable exits
- Wesana Health
Portfolio context
Notable portfolio companies include: Wesana Health: A psychedelic life-sciences company focused on psilocybin-based medicine for traumatic brain injury. Cybin: Developing psychedelic therapies aimed at mental health solutions. Field Trip Health: Specializes in psychedelic-assisted therapies. Eleusis: Engaged in psychedelic research and development. Psychedelic Water: Offers products related to psychedelics. atai Life Sciences: A biotechnology company focused on mental health.
Common questions
What to know about Ambria Capital, LLC
Upseed classifies Ambria Capital, LLC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.